| Luke Hyder, MD | |
|
530 Fontaine St, Pensacola, FL 32503-2019 | |
| (850) 474-4775 | |
| (850) 484-8223 |
| Full Name | Luke Hyder |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 11 Years |
| Location | 530 Fontaine St, Pensacola, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699115014 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ND0101X | Dermatology - Mohs-micrographic Surgery | ME131034 (Florida) | Secondary |
| 207N00000X | Dermatology | ME 131034 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Stat Home Health Florida Panhandle Llc | Pensacola, FL | Home health agency |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Forefront Dermatology | 3779471701 | 474 |
News Archive
The national study will look at the best clinical practice for treating pregnant women with schizophrenia and other psychosis by setting up an Australian wide database of pregnant women with schizophrenia and related disorders. The study will follow the woman and her baby during pregnancy up to the first year of the baby's life.
Researchers from the Hospital Clinic of Barcelona (Spain) have reviewed ten years' worth of scientific studies on mitochondrial toxicity in pregnant women. Exposure to toxic agents such as viruses, certain drugs, pesticides, alcohol and tobacco cause mitochondrial diseases about which very little is known, and which are transmitted from the mother to the foetus.
The U.S. Food and Drug Administration today approved Brisdelle (paroxetine) to treat moderate to severe hot flashes (vasomotor symptoms) associated with menopause. Brisdelle, which contains the selective serotonin reuptake inhibitor paroxetine mesylate, is currently the only non-hormonal treatment for hot flashes approved by the FDA.
A drug that relieves the severe symptoms of a life-threatening bone marrow cancer called myelofibrosis also improves the survival of patients with the disease, according to a phase III clinical trial published in the March 1 edition of New England Journal of Medicine.
› Verified 7 days ago
| Entity Name | Forefront Dermatology Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154815546 PECOS PAC ID: 3779471701 Enrollment ID: O20181019000122 |
News Archive
The national study will look at the best clinical practice for treating pregnant women with schizophrenia and other psychosis by setting up an Australian wide database of pregnant women with schizophrenia and related disorders. The study will follow the woman and her baby during pregnancy up to the first year of the baby's life.
Researchers from the Hospital Clinic of Barcelona (Spain) have reviewed ten years' worth of scientific studies on mitochondrial toxicity in pregnant women. Exposure to toxic agents such as viruses, certain drugs, pesticides, alcohol and tobacco cause mitochondrial diseases about which very little is known, and which are transmitted from the mother to the foetus.
The U.S. Food and Drug Administration today approved Brisdelle (paroxetine) to treat moderate to severe hot flashes (vasomotor symptoms) associated with menopause. Brisdelle, which contains the selective serotonin reuptake inhibitor paroxetine mesylate, is currently the only non-hormonal treatment for hot flashes approved by the FDA.
A drug that relieves the severe symptoms of a life-threatening bone marrow cancer called myelofibrosis also improves the survival of patients with the disease, according to a phase III clinical trial published in the March 1 edition of New England Journal of Medicine.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Luke Hyder, MD 801 York St, Manitowoc, WI 54220-4630 Ph: (920) 663-9008 | Luke Hyder, MD 530 Fontaine St, Pensacola, FL 32503-2019 Ph: (850) 474-4775 |
News Archive
The national study will look at the best clinical practice for treating pregnant women with schizophrenia and other psychosis by setting up an Australian wide database of pregnant women with schizophrenia and related disorders. The study will follow the woman and her baby during pregnancy up to the first year of the baby's life.
Researchers from the Hospital Clinic of Barcelona (Spain) have reviewed ten years' worth of scientific studies on mitochondrial toxicity in pregnant women. Exposure to toxic agents such as viruses, certain drugs, pesticides, alcohol and tobacco cause mitochondrial diseases about which very little is known, and which are transmitted from the mother to the foetus.
The U.S. Food and Drug Administration today approved Brisdelle (paroxetine) to treat moderate to severe hot flashes (vasomotor symptoms) associated with menopause. Brisdelle, which contains the selective serotonin reuptake inhibitor paroxetine mesylate, is currently the only non-hormonal treatment for hot flashes approved by the FDA.
A drug that relieves the severe symptoms of a life-threatening bone marrow cancer called myelofibrosis also improves the survival of patients with the disease, according to a phase III clinical trial published in the March 1 edition of New England Journal of Medicine.
› Verified 7 days ago
Dr. Kevin L Welch, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 8333 N Davis Hwy, West Florida Medical Center Clinic Pa, Pensacola, FL 32514 Phone: 850-474-8386 Fax: 850-474-8522 | |
Robert Macneal, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 8333 N Davis Hwy, Pensacola, FL 32514 Phone: 850-474-8386 Fax: 850-474-8522 | |
Dr. Mary Foscue, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1601 E Heinberg St, Pensacola, FL 32502 Phone: 850-304-3997 Fax: 850-304-3997 | |
Mr. Boyd A Skinner, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1800 N E St, Pensacola, FL 32501 Phone: 850-434-3000 Fax: 850-469-8196 | |
William G Trent, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 312 Kenmore Rd, Pensacola, FL 32503 Phone: 850-471-7589 | |
Dr. David A Gaston Ii, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 8333 N Davis Hwy, West Florida Medical Center Clinic Pa, Pensacola, FL 32514 Phone: 850-474-8386 Fax: 850-474-8522 | |
Justin L Shields Iii, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 540 Fontaine St, Pensacola, FL 32503 Phone: 850-484-4775 Fax: 850-484-4775 |